SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-24-074737 from ALUMIS INC. (ALMS)

ALUMIS INC.
Date: June 25, 2024 · CIK: 0001847367 · Accession: 0001104659-24-074737

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-280068

Date
June 25, 2024
Author
Director
Form
CORRESP
Company
ALUMIS INC.

Letter

June 25, 2024

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attn: Jessica Dickerson, Franklin Wyman, Kevin Vaughn, Tim Buchmiller

Re: Alumis Inc.

Registration Statement on Form S-1

File No. 333-280068

Acceleration Request

Requested Date: June 27,

Requested Time: 4:00 p.m., Eastern Time

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), Morgan Stanley & Co. LLC, Leerink Partners LLC, Cantor Fitzgerald & Co. and Guggenheim Securities, LLC, as representatives of the several underwriters, hereby join Alumis Inc. in requesting that the Securities and Exchange Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-280068) (the “Registration Statement”) to become effective on June 27, 2024, at 4:00 p.m., Eastern Time, or as soon as practicable thereafter.

Pursuant to Rule 460 under the Act, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus, to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.

We, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, to the extent applicable.

[Signature Page Follows]

Very
truly yours,
MORGAN
STANLEY & CO. LLC

Show Raw Text
CORRESP
1
filename1.htm

June 25, 2024

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attn: Jessica Dickerson, Franklin Wyman, Kevin Vaughn, Tim Buchmiller

    Re:
    Alumis Inc.

    Registration Statement on Form S-1

    File No. 333-280068

    Acceleration Request

    Requested Date:  June 27,
2024

    Requested Time: 4:00
p.m., Eastern Time

Ladies and Gentlemen:

In accordance with Rule 461
under the Securities Act of 1933, as amended (the “Act”), Morgan Stanley & Co. LLC, Leerink Partners
LLC, Cantor Fitzgerald & Co. and Guggenheim Securities, LLC, as representatives of the several underwriters, hereby join Alumis
Inc. in requesting that the Securities and Exchange Commission take appropriate action to cause the Registration Statement on Form S-1
(File No. 333-280068) (the “Registration Statement”) to become effective on June 27, 2024, at 4:00
p.m., Eastern Time, or as soon as practicable thereafter.

Pursuant to Rule 460
under the Act, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus, to
underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.

We, as representatives of
the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied
and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, to the extent applicable.

[Signature Page Follows]

    Very
    truly yours,

    MORGAN
    STANLEY & CO. LLC

    LEERINK
    PARTNERS LLC

    CANTOR
    FITZGERALD & CO.

    GUGGENHEIM
    SECURITIES, LLC

    As
    representatives of the Underwriters

    MORGAN
    STANLEY & CO. LLC

    By:
    /s/
    Chirag D. Surti

    Name: Chirag
D. Surti

    Title: Executive
Director

    Leerink
    Partners LLC

    By:
    /s/
    Dan Dubin, M.D.

    Name: Dan Dubin, M.D.

    Title: Vice Chairman, Global Co-Head of Healthcare Investment Banking

    Cantor
    Fitzgerald & Co.

    By:
    /s/
    Jason Fenton

    Name: Jason
Fenton

    Title: Global
Co-Head of ECM

    Guggenheim
    Securities, LLC

    By:
    /s/
Jordan Bliss

    Name: Jordan Bliss

    Title: Senior Managing Director

    cc:
    Roy
    Hardiman, Chief Business and Legal Officer, Alumis Inc.

    Sara
    Klein, General Counsel, Alumis Inc.

    David
    Peinsipp, Cooley LLP

    Kristin
    VanderPas, Cooley LLP

    B.
    Shayne Kennedy, Latham & Watkins LLP

    J.
    Ross McAloon, Latham & Watkins LLP

[Signature Page to Acceleration Request]